Correlation Between SAB Biotherapeutics and Oragenics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Oragenics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Oragenics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Oragenics, you can compare the effects of market volatilities on SAB Biotherapeutics and Oragenics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Oragenics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Oragenics.
Diversification Opportunities for SAB Biotherapeutics and Oragenics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SAB and Oragenics is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Oragenics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oragenics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Oragenics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oragenics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Oragenics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Oragenics
Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 13.11 times more return on investment than Oragenics. However, SAB Biotherapeutics is 13.11 times more volatile than Oragenics. It trades about 0.11 of its potential returns per unit of risk. Oragenics is currently generating about -0.03 per unit of risk. If you would invest 14.00 in SAB Biotherapeutics on January 10, 2025 and sell it today you would lose (11.39) from holding SAB Biotherapeutics or give up 81.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 77.43% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Oragenics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Oragenics |
SAB Biotherapeutics and Oragenics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Oragenics
The main advantage of trading using opposite SAB Biotherapeutics and Oragenics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Oragenics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will offset losses from the drop in Oragenics' long position.| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |